Biomimetic silk biomaterials: Perlecan-functionalized silk fibroin for use in blood-contacting devices
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Acta Biomaterialia
- Vol. 132, 162-175
Abstract
No abstract availableKeywords
Funding Information
- NSW Ministry of Health
- National Heart Foundation of Australia (101896)
- Australian Research Council (DE160101308)
- Australian Research Council (DP150104242)
- Department of Education and Training
- Universidade Estadual de Maringá
- Heart Research Institute
- University of New South Wales
- University of Sydney
- Ministry of Science and Innovation, New Zealand
This publication has 54 references indexed in Scilit:
- A Biomimetic Approach toward Enhancing Angiogenesis: Recombinantly Expressed Domain V of Human Perlecan Is a Bioactive Molecule That Promotes Angiogenesis and Vascularization of Implanted BiomaterialsAdvanced Science, 2020
- The blood compatibility challenge. Part 4: Surface modification for hemocompatible materials: Passive and active approaches to guide blood-material interactionsActa Biomaterialia, 2019
- The blood compatibility challenge. Part 1: Blood-contacting medical devices: The scope of the problemActa Biomaterialia, 2019
- Glycosaminoglycan and Proteoglycan‐Based Biomaterials: Current Trends and Future PerspectivesAdvanced Healthcare Materials, 2017
- Recombinant Domain V of Human Perlecan Is a Bioactive Vascular ProteoglycanBiotechnology Journal, 2017
- Recombinant production of proteoglycans and their bioactive domainsThe FEBS Journal, 2013
- Mast Cells Produce Novel Shorter Forms of Perlecan That Contain Functional EndorepellinJournal of Biological Chemistry, 2013
- The modulation of platelet and endothelial cell adhesion to vascular graft materials by perlecanBiomaterials, 2009
- Perlecan: how does one molecule do so many things?Cellular and Molecular Life Sciences, 2006
- Physiology of the endotheliumBritish Journal of Anaesthesia, 2004